Atreca, Inc. (BCEL)
OTCMKTS: BCEL · Delayed Price · USD
0.0825
-0.0030 (-3.51%)
Apr 26, 2024, 10:09 AM EDT - Market open

Atreca Market Cap

Atreca has a market cap or net worth of $3.27 million as of April 26, 2024. Its market cap has decreased by -94.06% in one year.

Market Cap
3.27M
Enterprise Value
-16.72M
1-Year Change
-94.06%
Ranking
n/a
Category
Stock Price
$0.08

Market Cap Chart

Since June 20, 2019, Atreca's market cap has decreased from $483.50M to $3.27M, a decrease of -99.32%. That is a compound annual growth rate of -65.08%.

History

DateMarket Cap% Change
Mar 18, 20245.90M-11.94%
Mar 15, 20246.70M-15.19%
Mar 14, 20247.90M5.33%
Mar 13, 20247.50M11.94%
Mar 12, 20246.70M-20.24%
Mar 11, 20248.40M-5.62%
Mar 8, 20248.90M-3.26%
Mar 7, 20249.20M-
Mar 6, 20249.20M-6.12%
Mar 5, 20249.80M-2.00%
Mar 4, 202410.00M-6.54%
Mar 1, 202410.70M3.88%
Feb 29, 202410.30M-2.83%
Feb 28, 202410.60M-0.93%
Feb 27, 202410.70M-7.76%
Feb 26, 202411.60M-3.33%
Feb 23, 202412.00M-3.23%
Feb 22, 202412.40M7.83%
Feb 21, 202411.50M-7.26%
Feb 20, 202412.40M0.81%
Feb 16, 202412.30M-1.60%
Feb 15, 202412.50M8.70%
Feb 14, 202411.50M15.00%
Feb 13, 202410.00M8.70%
Feb 12, 20249.20M-5.15%
View and export this data all the way back to 2019. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 696.15B
Novo Nordisk 573.09B
UnitedHealth Group 449.26B
Johnson & Johnson 357.92B
Merck & Co. 321.65B
AbbVie 297.12B
AstraZeneca 220.71B
Thermo Fisher 220.40B
Market Cap Rankings